PUBLISHER: The Business Research Company | PRODUCT CODE: 1712353
PUBLISHER: The Business Research Company | PRODUCT CODE: 1712353
Cardiovascular monitoring and diagnostic devices are essential tools used in diagnosing, monitoring, and treating cardiovascular conditions.
The primary product categories in this market encompass cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and Holter monitoring systems. ECG monitoring equipment, for example, functions as an electronic tool to record the heart's electrical activity. These devices are utilized for specific conditions like heart disease and coronary heart disease. They find application across various sectors, including hospitals, physician clinics, emergency settings, and research and development purposes in settings such as clinical trials, universities, and CROs.
The cardiovascular monitoring and diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiovascular monitoring and diagnostic devices and equipment market statistics, including cardiovascular monitoring and diagnostic devices and equipment industry global market size, regional shares, competitors with a cardiovascular monitoring and diagnostic devices and equipment market share, detailed cardiovascular monitoring and diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular monitoring and diagnostic devices and equipment industry. This cardiovascular monitoring and diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular monitoring and diagnostic devices and equipment market size has grown strongly in recent years. It will grow from $4.21 billion in 2024 to $4.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, preventive healthcare, telemedicine integration.
The cardiovascular monitoring and diagnostic devices and equipment market size is expected to see steady growth in the next few years. It will grow to $5.37 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to personalized medicine, digital health, chronic disease management, remote patient monitoring. Major trends in the forecast period include wearable and mobile monitoring, ai-enhanced diagnostics, point-of-care testing, remote cardiac rehabilitation.
Enhanced healthcare infrastructure is expected to drive the growth of the cardiovascular monitoring and diagnostic devices and equipment market in the coming years. Healthcare infrastructure refers to the physical facilities, personnel, buildings, and systems required to provide healthcare services that meet the health needs of target populations. It plays a critical role in the development, implementation, and effective use of cardiovascular monitoring and diagnostic devices. A robust healthcare infrastructure ensures access to safe, effective, and high-quality medical devices, which are essential for preventing, diagnosing, and treating cardiovascular diseases. For example, according to the National Health Expenditure Account (NHEA) published by the Centers for Medicare and Medicaid Services, a U.S.-based federal agency, U.S. healthcare spending grew by 2.7% in 2021, reaching $4.3 trillion, or $12,914 per person. Health spending accounted for 18.3% of the nation's Gross Domestic Product (GDP). As such, enhanced healthcare infrastructure is driving the growth of the cardiovascular monitoring and diagnostic devices and equipment market.
The cardiovascular monitoring and diagnostic devices and equipment market is being driven by the increasing prevalence of obesity and diabetes. Both of these conditions are associated with risk factors such as high blood pressure and high cholesterol, which contribute to the development of cardiovascular diseases. For example, a study conducted by the American Heart Association (AHA) predicts that by 2030, the number of people affected by cardiovascular diseases (CVD) will grow to 22.2 million. Additionally, another study by the AHA in the U.S. found that 26 million people have been diagnosed with diabetes, while more than 9 million others are living with undiagnosed diabetes. These growing health challenges are driving demand for advanced cardiovascular monitoring and diagnostic devices and equipment.
Leading companies in the cardiovascular monitoring and diagnostic devices market are introducing cutting-edge solutions like the LUX-Dx II+ to cater to patients' needs effectively. The LUX-Dx II+ insertable cardiac monitor (ICM) system represents the next generation in ICM technology, offering physicians a fresh diagnostic evaluation and prolonged monitoring option for individuals with irregular heart rhythms. In October 2023, Boston Scientific, a US-based firm, introduced the LUX-Dx II+ system, featuring advanced dual-stage algorithms, high-quality S-ECG signal clarity, remote programming capabilities, wireless connectivity, a dedicated patient app, and a compact design.
The rise of new product launches stands out as a significant trend in the market for cardiovascular monitoring and diagnostic devices and equipment. Companies within the sector are emphasizing the introduction of new products to enhance their product line and fortify their market presence. As an illustration, in August 2022, SmartCardia SA, a Switzerland-based medical equipment manufacturer, introduced the 7L patch, a 7-lead cardiac monitoring patch in the Indian market. This monitoring patch integrates medical wearable technology with artificial intelligence (AI) to deliver predictive and personalized patient insights through remote monitoring. The 7L patch, monitored by SmartCardia's AI platform, is analyzed by certified cardiac technicians and cardiologists, enabling real-time detection of critical arrhythmia events with accuracy comparable to that of cardiologists.
In May 2024, WearLinq Inc., a U.S.-based provider of digital healthcare solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. With this acquisition, WearLinq aims to strengthen its position in the ambulatory cardiac monitoring market by expanding nationwide access to its FDA-cleared eWave 6-lead ECG monitor and enhancing cardiac diagnostics through AMI's clinical expertise. AMI Cardiac Monitoring LLC, a U.S.-based, privately held, Medicare-certified independent diagnostic testing company, specializes in offering cardiovascular monitoring and diagnostic devices and equipment.
Major companies operating in the cardiovascular monitoring and diagnostic devices and equipment market include Medtronic PLC, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Philips Healthcare, Siemens Healthcare, St. Jude MedicalInc., Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Sorin Group, Welch Allyn Inc., LivaNova PLC, Spacelabs Healthcare, Opto Circuits India Ltd., BPL Health Management Solutions, OSI Systems Inc., Hill-Rom Holdings Inc., Schiller AG, Abbott Cardiovascular, Accellent Inc., Aerotel medical systems Ltd., Asahi Kasei Corporation, Bioheart Inc., Biosensors international group Ltd., Cook group incorporated, Drager Medical AG & Co. KGaA., Molecular devices LLC, Edwards Lifesciences Corp., Biotronik Inc., Koninklijke Philips N.V., Endotronix Inc., Smartcardia, Personal Safety Corporation, Ivy Biomedical Systems Inc., Cardio Diagnostics Holdings Inc., ECG Excellence BV, Aktiia SA, HD Medical, HeartFlow Inc., VPG Medical, BioTelemetry Inc., Preventice Solutions, Mortara Instrument Inc., Getemed Medizin-Und Informationstechnik Ag, LifeWatch Technologies Ltd., QRS Diagnostic
North America was the largest region in global cardiovascular monitoring and diagnostic devices and equipment market in 2024. Western Europe was the second-largest region in cardiovascular monitoring and diagnostic devices and equipment market. The regions covered in the cardiovascular monitoring and diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the cardiovascular monitoring and diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The cardiovascular monitoring and diagnostic devices and equipment market consist of sales of cardiopulmonary stress testing systems, electrocardiogram (ECG) data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and holter monitoring systems that are used for diagnosis and treatment of cardio diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cardiovascular monitoring and diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular monitoring and diagnostic devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular monitoring and diagnostic devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.